Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,179 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07632872RecruitingPhase 2
Adding Desloratadine to Rheumatoid Arthritis Treatment
This study tests whether desloratadine, an allergy medication, can help reduce rheumatoid arthritis symptoms when added to your current treatments. Researchers want to see if it reduces joint swelling and pain alongside your existing therapy.
Al MansurahAges 18–60 - NCT07633756RecruitingPhase 1
Testing RB1-negative Leiomyosarcoma Treatment with REC-617
This study tests a new drug called REC-617 in patients with a rare muscle cancer (leiomyosarcoma) that has spread or cannot be surgically removed. The drug targets cancer cells that lack a specific protein called RB1, and you must have already tried at least one other cancer treatment before joining.
Houston, TexasAges 18 years+ - NCT07635732Recruiting
Urine Bacteria as a Test for Melanoma Treatment Response
This study looks at bacteria naturally found in urine to see if they can help diagnose melanoma and predict how well systemic therapy (medicine that spreads throughout the body) will work. Researchers believe the types of bacteria in your urine may reflect how your immune system is responding to melanoma treatment.
Gratwein, StyriaAges 18 years+ - NCT07630142Recruiting
Massage methods for chronic neck pain: an imaging study
This trial compares two types of massage—long, gentle strokes versus a handheld massager—for relieving long-lasting neck pain. Ultrasound imaging will be used to see how the muscles respond.
PoznanAges 18–60 - NCT07637877RecruitingPhase 2
Treatments to boost immune recovery in HIV
This study tests new treatments to help people with HIV who have low CD4 counts despite antiretroviral therapy. It aims to improve immune function and reduce the risk of infections.
Beijing, Beijing MunicipalityAges 18–60 - NCT07630350Enrolling by invitation
Virtual Reality for Young People With Chronic Pain
This study tests whether wearing virtual reality goggles can help young people (ages 7–21) manage chronic pain in their neck, shoulders, or arms. Researchers want to see if VR activities can reduce pain and improve daily life.
Allison Park, PennsylvaniaAges 7–21 - NCT07636135Recruiting
Early rehabilitation timing after neck spine surgery
This study tests whether starting physical therapy sooner after neck spine surgery for degenerative myelopathy (a condition where the spinal cord is compressed) helps patients recover strength, balance, and walking ability faster. You'll do 8 weeks of in-person rehabilitation in Edmonton, Alberta.
Edmonton, AlbertaAges 18 years+ - NCT07629635RecruitingPhase 3
Closing a heart hole to treat migraines
This trial tests whether closing a small hole in the heart (called a PFO) can help eliminate migraines. If you have frequent migraines and no other major health issues, this procedure might reduce or stop your headaches.
New York, New YorkAges 18–55 - NCT07631156RecruitingPhase 4
Safely Reducing Heart Failure Medications After Recovery
This study tests whether patients whose heart function has fully recovered after surgery or a heart procedure can safely reduce or stop their heart failure medications. Researchers will carefully monitor whether gradually lowering these medicines is safe and maintains heart health.
Daegu, DaeguAges 19 years+ - NCT07631182Recruiting
Action Observation Therapy for Stroke Recovery via Telehealth
This trial tests a therapy where you watch videos of hand and arm movements and then practice them yourself, delivered through video calls from home. It's designed to help people recover arm and hand function after a stroke.
Karabük, MerkezAges 18 years+ - NCT06160206RecruitingPhase 2
Study of retifanlimab, bevacizumab, and radiation for recurrent glioblastoma
This trial tests a combination of immunotherapy (retifanlimab), a targeted drug (bevacizumab), and low-dose radiation for people whose glioblastoma has come back. The goal is to see if this treatment can help shrink or slow the tumor.
Scottsdale, ArizonaAges 18 years+ - NCT06526728RecruitingPhase 3
Hyperbaric oxygen therapy for acute hamstring injuries
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) helps people with a recent hamstring strain recover faster and return to sports or duty. It is for adults with an injury that happened within the last 7 days.
Amsterdam, North HollandAges 18–65 - NCT07621471RecruitingEarly Phase 1
NK Cell Therapy Enhanced with IL-15 for Advanced Solid Tumors
This early-stage trial tests a new type of immune cell therapy (NK cells boosted with a protein called IL-15) to treat solid cancers that have spread or come back after standard treatment. The goal is to see if this approach can help shrink tumors and improve survival.
ChongqingAges 18–70 - NCT07622186RecruitingPhase 2
SKB571 combination therapy for advanced lung cancer
This trial tests a new drug called SKB571, given in combination with other treatments, for non-small cell lung cancer (a common type of lung cancer). The study aims to see if this combination helps shrink tumors and improve survival.
Beijing, Beijing MunicipalityAges 18–75 - NCT07629115Recruiting
Long-term follow-up study for severe Parkinson's gene therapy
This study follows patients who previously received IPS101A, an experimental gene therapy treatment for severe Parkinson's disease. Researchers want to check how you're doing over time and gather information about the treatment's long-term effects.
SeoulAges 50–80 - NCT07623200RecruitingPhase 3
New drug for high-risk essential thrombocythemia with specific genetic mutation
This study tests a new drug called INCA033989 for people with a high-risk form of essential thrombocythemia (a blood disorder causing too many platelets) who have a specific genetic change called mutCALR. The trial compares this new drug to the best currently available treatments.
Birmingham, AlabamaAges 18 years+ - NCT06693024Recruiting
Neratinib after standard therapy for HER2-positive early breast cancer
This trial is testing whether adding neratinib after standard treatment helps prevent HER2-positive early breast cancer from coming back. It is open only to patients treated at Peking University People's Hospital.
Beijing, Beijing MunicipalityAges Any age - NCT06696833RecruitingEarly Phase 1
CD19-targeted CAR-T cell therapy for relapsed B-ALL
This trial tests a new type of immune cell therapy (CAR-γδT cells) that targets CD19 on leukemia cells. It is for people with B-cell acute lymphoblastic leukemia that has not responded to treatment or has come back.
Suzhou, China, JiangsuAges 14 years+ - NCT07627438Recruiting
Pelvic Floor Exercises for Premature Ejaculation
This trial tests whether targeted pelvic floor muscle exercises can help men with lifelong premature ejaculation last longer during intercourse. The study focuses on strengthening the muscles that control ejaculation through physical therapy techniques.
Tanta, TantaAges 18–50 - NCT07625202Recruiting
Creatine Supplements During GLP-1 Weight-Loss Therapy
This trial tests whether adding creatine (a natural muscle-building supplement) helps preserve muscle and strength while taking GLP-1 medications like Ozempic or Wegovy. These medications help with weight loss but can sometimes cause muscle loss, so researchers want to see if creatine prevents that.
Saskatoon, SK - SaskatchewanAges 18 years+ - NCT07626450Recruiting
Hyperbaric oxygen after stroke clot removal treatment
This study tests whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can help recovery after emergency clot-removal surgery for large blood vessel strokes. The goal is to see if extra oxygen can reduce brain damage and improve outcomes.
Beijing, Beijing MunicipalityAges 18–80 - NCT07626086Recruiting
Pilates exercises to improve balance and quality of life after kidney transplant
This study tests whether pilates exercises can help kidney transplant patients improve their balance, reduce fatigue, and feel better overall. You would do pilates workouts over several weeks while researchers track how you feel and function.
Damanhur, BeheiraAges 20–50 - NCT07628348Recruiting
Physical therapy for neck pain from disc herniation
This study tests a physical therapy technique called DRT (Diaphragmatic Respiration Training) to help patients with neck pain, tingling in the arm, and limited neck movement caused by a slipped disc in the neck. The goal is to improve neck flexibility, reduce pain, and expand the chest.
Lahore, Punjab ProvinceAges 35–55 - NCT07625241Recruiting
Brain and Movement Training for Mild-to-Moderate Dementia
This study tests two types of training—cognitive (brain) and movement exercises—for people with mild-to-moderate dementia. The goal is to see if these activities together can help improve thinking, memory, and physical function.
Genova, GenovaAges 65 years+
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,179 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.